A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/565 (2006.01)
Patent
CA 2210811
Disclosed is a pharmaceutical composition for oral delivery. The composition includes about 1-2 mg mammalian estrogen and about 25-100 mg phytoestrogen. Compositions of the type described above are utilized, for example, in a therapeutic regimen designed to reduce the risk of coronary heart disease and osteoporosis in postmenopausal women. This method comprises the oral administration of a composition comprising a mixture of estrogen and phytoestrogen, the dosages of mammalian estrogen and phytoestrogen being about 1-2 mg, about 25-100 mg, respectively.
Préparation pharmaceutique à administration par voie orale, comportant environ 1-2 mg d'oestrogène de mammifère et environ 25-100 mg de phytoestrogènes pouvant par exemple être utilisés selon un régime thérapeutique visant à réduire les risques de maladies coronariennes et d'ostéoporose chez les femmes post ménopausées. La méthode associée comprend l'administration par voie orale d'une composition contenant un mélange d'oestrogène et de phytoestrogène de mammifère selon un dosage respectif d'environ 1 à 2 mg et d'environ 25 à 100 mg.
Clarkson Thomas B.
Henley Edna C.
Hughes Claude L.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Protein Technologies International Inc.
Wake Forest University
LandOfFree
Dietary phytoestrogen in estrogen replacement therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dietary phytoestrogen in estrogen replacement therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dietary phytoestrogen in estrogen replacement therapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2053647